Home › Funds › Vanguard › Equity Income Portfolio
Fund family: Vanguard · Filed by VANGUARD VARIABLE INSURANCE FUNDS (CIK 857490) · SEC series S000004399
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,493 with, 139 against, 0 abstentions (not counted as with management). Shareholder proposals: 7 FOR, 128 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Vanguard | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 99.2% | 2,424 | 94.5% | 1,082,514 |
| Backed environmental and social shareholder proposals at US companies | 0.0% | 59 | 0.9% | 6,718 |
Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Vanguard funds on 19 items (0.7% of the 2,592 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Vanguard funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| The Progressive Corporation | 2026-05-08 | Election of Directors: Lawton W. Fitt | Against | FOR — 31 of 33 Vanguard funds | For | Elected, 85.8% support |
| L3Harris Technologies, Inc. | 2026-05-11 | Shareholder Shareholder Proposal titled "Improve Shareholder Ability to Call for a Special Shareholder Meeting". | For | AGAINST — 24 of 26 Vanguard funds | Against | — |
| Zoetis Inc. | 2026-05-20 | Shareholder Shareholder proposal to permit shareholder action by written consent. | For | AGAINST — 24 of 26 Vanguard funds | For | — |
| American International Group, Inc. | 2026-05-13 | Advisory Vote to Approve Named Executive Officer Compensation. | Against | FOR — 32 of 36 Vanguard funds | For | Passed (calculated), 77.5% support |
| American International Group, Inc. | 2026-05-13 | Election of Directors: DIANA M. MURPHY | Against | FOR — 28 of 31 Vanguard funds | For | Elected, 91.2% support |
| American International Group, Inc. | 2026-05-13 | Election of Directors: JUAN R. PEREZ | Against | FOR — 28 of 31 Vanguard funds | For | Elected, 91.9% support |
| American International Group, Inc. | 2026-05-13 | Election of Directors: LINDA A. MILLS | Against | FOR — 28 of 31 Vanguard funds | For | Elected, 88.9% support |
| Pfizer Inc. | 2026-04-23 | Shareholder Adopt an Independent Chair Policy | For | AGAINST — 25 of 28 Vanguard funds | For | Not approved, 28.8% support |
| Regions Financial Corporation | 2026-05-06 | Shareholder Shareholder Proposal Relating to Special Shareholder Meeting. | For | AGAINST — 24 of 27 Vanguard funds | Against | Not approved, 43.9% support |
| Accenture Plc | 2026-01-28 | To approve, in a non-binding vote, the compensation of our named executive officers. | Against | FOR — 33 of 40 Vanguard funds | For | — |
| Ares Management Corporation | 2026-06-08 | Election of Directors: Antoinette Bush | For | AGAINST — 20 of 23 Vanguard funds | For | Elected, 94.3% support |
| Ares Management Corporation | 2026-06-08 | Election of Directors: Antony P. Ressler | For | AGAINST — 20 of 23 Vanguard funds | For | Elected, 92.5% support |
| Ares Management Corporation | 2026-06-08 | Election of Directors: Dr. Judy D. Olian | For | AGAINST — 20 of 23 Vanguard funds | For | Elected, 92.4% support |
| Ares Management Corporation | 2026-06-08 | Election of Directors: Michael J Arougheti | For | AGAINST — 20 of 23 Vanguard funds | For | Elected, 93.9% support |
| Eaton Corporation plc | 2026-04-22 | Election of Directors: Gregory R. Page | Against | FOR — 11 of 13 Vanguard funds | Against | — |
| Eli Lilly and Company | 2026-05-04 | Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. | For | AGAINST — 27 of 37 Vanguard funds | Against | Not approved, 33.7% support |
| NXP Semiconductors N.V. | 2026-06-10 | Appoint Gregory Summe as non-executive director | Against | FOR — 10 of 14 Vanguard funds | Against | Passed (calculated), 85.9% support |
| NXP Semiconductors N.V. | 2026-06-10 | Appoint Karl-Henrik Sundstrom as non-executive director | Against | FOR — 10 of 14 Vanguard funds | Against | Passed (calculated), 92.5% support |
| AstraZeneca plc | 2026-04-09 | Elect Marcus Wallenberg | Against | FOR — 4 of 7 Vanguard funds | Against | — |
Download all 19 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 93.4% of this fund’s 2,632 such votes could be given a sector; the other 174 (6.6%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 578 | 30 | 5.2% |
| Consumer Discretionary | 395 | 34 | 8.6% |
| Utilities | 270 | 9 | 3.3% |
| Industrials | 267 | 12 | 4.5% |
| Health Care | 246 | 16 | 6.5% |
| Technology | 244 | 12 | 4.9% |
| Energy | 148 | 6 | 4.1% |
| Consumer Staples | 139 | 13 | 9.4% |
| Telecommunications | 99 | 7 | 7.1% |
| Miscellaneous | 37 | 0 | 0.0% |
| Real Estate | 35 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,912 | 4 |
| Audit-related | 193 | 0 |
| Say-on-Pay | 181 | 2 |
| Corporate Governance | 127 | 64 |
| Compensation | 81 | 3 |
| Capital Structure | 55 | 0 |
| Environment or Climate | 30 | 29 |
| Other Social Issues | 23 | 21 |
| Shareholder Rights and Defenses | 15 | 6 |
| Extraordinary Transactions | 10 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Broadcom Inc. | April 20, 2026 | $4.4B | 12 | 0 |
| Merck & Co., Inc. | May 26, 2026 | $3.1B | 19 | 3 |
| Johnson & Johnson | April 23, 2026 | $2.5B | 15 | 1 |
| Bank of America Corporation | May 4, 2026 | $2.1B | 28 | 2 |
| Cisco Systems, Inc. | December 16, 2025 | $2.1B | 25 | 1 |
| Keurig Dr Pepper Inc. | June 16, 2026 | $2.0B | 12 | 0 |
| Diamondback Energy, Inc. | May 20, 2026 | $1.8B | 16 | 0 |
| Marsh & McLennan Companies, Inc. | May 21, 2026 | $1.5B | 17 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| May 4, 2026 | Bank of America Corporation | Shareholder proposal requesting independent board chair Shareholder proposal | Against | For |
| May 4, 2026 | Bank of America Corporation | Shareholder proposal requesting report on board oversight of risks related to animal welfare Shareholder proposal | Against | For |
| December 16, 2025 | Cisco Systems, Inc. | Stockholder Proposal - Approval to request the Board to conduct an evaluation and issue a report assessing how Cisco's Inclusion programs provide positive financial value to shareholders. Shareholder proposal | Against | For |
| May 22, 2026 | Honeywell International Inc. | Shareowner Proposal - Shareholder Right to Act by Written Consent. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 6, 2026 | Philip Morris International Inc. | Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposal | Against | For |
| May 13, 2026 | Elevance Health, Inc. | Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposal | Against | For |
| May 5, 2026 | Dominion Energy, Inc. | Shareholder Proposal Regarding a Policy for an Independent Chair Shareholder proposal | Against | For |
2,636 ballot items at 193 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Equity Income Portfolio voted at 193 shareholder meetings of 182 companies, on 2,636 ballot items in all. Where management made a recommendation, the fund followed it on 94.7% of the items and voted against it 139 times. Its most frequent area of disagreement was corporate governance (64 of its votes against management). It voted FOR 5.2% of the 135 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (99.2% against 94.5%). It voted differently from most Vanguard funds on 19 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.